IGF-1 exacerbates the neurotoxicity of the mitochondrial inhibitor 3NP in rats.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Neuroscience Letters

• Publication date

  2007-10-02

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.NEULET.2007.08.031PMID 17868993
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Involvement of mitochondrial complex II defects in neuronal death produced by N-terminus fragment of mutated huntingtin.

  2006influential reference
• Brain mitochondrial defects amplify intracellular [Ca2+] rise and neurodegeneration but not Ca2+ entry during NMDA receptor activation

  2006cited by this paper
• 3‐Nitropropionic acid: a mitochondrial toxin to uncover physiopathological mechanisms underlying striatal degeneration in Huntington's disease

  2005cited by this paper
• Molecular physiology, pathology, and regulation of the growth hormone/insulin-like growth factor-I system

  2005cited by this paper
• p53 mediates cellular dysfunction and behavioral abnormalities in Huntington's disease.

  2005cited by this paper
• Minocycline in phenotypic models of Huntington's disease.

  2005cited by this paper
• Insulin growth factor-1 protects against excitotoxicity in the rat striatum

  2004cited by this paper
• Microspheres containing insulin-like growth factor I for treatment of chronic neurodegeneration.

  2004cited by this paper
• Targeting energy metabolism in Huntington's disease.

  2004cited by this paper
• Central effects of the somatotropic system.

  2003cited by this paper
• Calpain Is a Major Cell Death Effector in Selective Striatal Degeneration Induced In Vivo by 3-Nitropropionate: Implications for Huntington's Disease

  2003cited by this paper
• Brain repair and neuroprotection by serum insulin-like growth factor I

  2003cited by this paper
• Retrograde Viral Delivery of IGF-1 Prolongs Survival in a Mouse ALS Model

  2003cited by this paper
• Serum insulin-like growth factor I regulates brain amyloid-beta levels.

  2002cited by this paper
• Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines

  2002influential reference
• Corticostriatopallidal Neuroprotection by Adenovirus-Mediated Ciliary Neurotrophic Factor Gene Transfer in a Rat Model of Progressive Striatal Degeneration

  2002cited by this paper
• The IGF-1/Akt pathway is neuroprotective in Huntington's disease and involves Huntingtin phosphorylation by Akt.

  2002influential reference
• Neuronal Death by Accident or by Design

  2001cited by this paper
• Neuronal Death in Huntington’s Disease: Multiple Pathways for One Issue?

  2001cited by this paper
• Circulating Insulin-Like Growth Factor I Mediates the Protective Effects of Physical Exercise against Brain Insults of Different Etiology and Anatomy

  2001cited by this paper
• Intranasal administration of insulin-like growth factor-I bypasses the blood-brain barrier and protects against focal cerebral ischemic damage.

  2001cited by this paper
• Energetics in the pathogenesis of neurodegenerative diseases.

  2000cited by this paper
• Mice transgenic for an expanded CAG repeat in the Huntington's disease gene develop diabetes.

  1999cited by this paper
• Replicating Huntington's disease phenotype in experimental animals.

  1999cited by this paper
• Molecular Physiology

  1998cited by this paper
• Neuroprotective Effects of Creatine and Cyclocreatine in Animal Models of Huntington’s Disease

  1998cited by this paper
• Riluzole reduces incidence of abnormal movements but not striatal cell death in a primate model of progressive striatal degeneration.

  1997cited by this paper
• Characterization of the Excitotoxic Potential of the Reversible Succinate Dehydrogenase Inhibitor Malonate

  1995cited by this paper
• A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group.

  1993cited by this paper
• A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group.

  1993cited by this paper
• Insulin-like growth factors I and II.

  1990cited by this paper
• Diabetes mellitus in Huntington disease

  1985cited by this paper

• Issues of pathogenetic relationships between neurochemical indices under the chronic mercury exposure

  2020cites this paper
• Intranasal Delivery: Effects on the Neuroimmune Axes and Treatment of Neuroinflammation

  2020cites this paper
• Effectiveness of Statin and Bisphosphonate Treatment in a 3NP model of Huntington’s Disease

  2015cites this paper
• Differential Effects of Delayed Aging on Phenotype and Striatal Pathology in a Murine Model of Huntington Disease

  2014cites this paper
• Isoform-Specific Toxicity of Mecp2 in Postmitotic Neurons: Suppression of Neurotoxicity by FoxG1

  2012cites this paper
• Pretreatment with Bacopa monnieri extract offsets 3-nitropropionic acid induced mitochondrial oxidative stress and dysfunctions in the striatum of prepubertal mouse brain.

  2012cites this paper
• Differential Effect of Fatty Acids in Nervous Control of Energy Balance

  2012influential citation
• Intranasal Administration of IGF-1 Protects against Lipopolysaccharide-induced Injury in the Developing Rat Brain

  2011influential citation
• Insulin-Like Growth Factor-1 Regulates Neurite Outgrowth and Neuronal Migration From Organotypic Cultured Dorsal Root Ganglion

  2011cites this paper
• Mesenchymal stem cell transplantation and DMEM administration in a 3NP rat model of Huntington's disease: morphological and behavioral outcomes.

  2011cites this paper
• Intranasal administration of insulin-like growth factor-1 protects against lipopolysaccharide-induced injury in the developing rat brain.

  2011cites this paper
• High insulinlike growth factor I is associated with cognitive decline in Huntington disease

  2011cites this paper
• Regulatory effects of insulin-like growth factor-1 on the expression of sensory neuropeptide mRNAs in cultured dorsal root ganglion neurons with excitotoxicity induced by glutamate

  2010cites this paper
• Insulin-like growth factor-1 modulates Ca2+ homeostasis and apoptosis of cultured dorsal root ganglion neurons with excitotoxicity induced by glutamate.

  2010cites this paper
• ROLE OF INSULIN AND IGF-1 IN ENERGY METABOLISM IN HUNTINGTON’S DISEASE: STUDIES IN CORTICAL AND STRIATAL NEURONS FROM YAC128 TRANSGENIC MICE AND HUMAN LYMPHOBLASTS

  2010cites this paper
• Regulatory effects of insulin-like growth factor-1 on the expression of sensory neuropeptide mRNAs in cultured dorsal root ganglion neurons with excitotoxicity induced by glutamate

  2010cites this paper
• Effects of Insulin-Like Growth Factor-1 on Expression of Sensory Neuropeptides in Cultured Dorsal Root Ganglion Neurons in the Absence or Presence of Glutamate

  2010cites this paper
• IGF-1 Can Either Protect Against or Increase LPS-Induced Damage in the Developing Rat Brain

  2010cites this paper
• Insulin like growth factor‐1 and insulin like growth factor binding proteins in the cerebrospinal fluid and serum from patients with Alzheimer's disease

  2008cites this paper